CoQ10

Best-in-class: Q10 Plus

A lipid-soluble antioxidant essential to mitochondrial ATP production; levels decline with age and with statin use.

How CoQ10 actually works

CoQ10 is the mobile electron carrier in the inner mitochondrial membrane, shuttling electrons from complexes I and II to complex III. Without it the electron transport chain simply stops, which is why the highest concentrations sit in the heart. The clinically important detail is where it comes from: your body makes it through the mevalonate pathway — the same pathway statins inhibit to lower cholesterol — so statins reduce CoQ10 synthesis as an unavoidable consequence of how they work. Ubiquinol is the reduced form and absorbs better, particularly with age.

Where to get CoQ10

The evidence for CoQ10

Graded by what exists behind each claim.

✅ Clinically validated

• RCTs/meta-analyses show benefit for heart-failure symptoms and functional capacity (adjunct).
• Reduces statin-associated muscle symptoms in a subset of users (mixed but supportive trials).
• Some RCT support for migraine prophylaxis and blood-pressure reduction.

📊 Correlative data

• Lower CoQ10 status tracks with age, statin therapy and cardiovascular disease severity.

🧪 Theoretical / extrapolated benefits

• Broad anti-aging/energy claims follow from its mitochondrial role but exceed the outcome data in healthy people.

How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →

What CoQ10 actually does

Coenzyme Q10 is the only lipid-soluble electron carrier in the inner mitochondrial membrane, and that is a structural job rather than an antioxidant one. It accepts electrons from complex I and complex II, and from electron-transferring flavoprotein dehydrogenase during fatty acid oxidation, and delivers them to complex III. Because it diffuses within the lipid bilayer rather than binding a fixed partner, it is the mobile link that lets several dehydrogenases feed one chain.

It is made by the same pathway a statin blocks, and that is the entire commercial premise. The benzoquinone ring comes from tyrosine and the ten-unit isoprenoid tail from farnesyl pyrophosphate in the mevalonate pathway, downstream of HMG-CoA reductase. Inhibiting that enzyme lowers circulating coenzyme Q10, reproducibly, by 16 to 54 percent Mantle 2023. Whether it lowers it inside muscle mitochondria is a different question and it is the question this page turns on.

The redox pair does two jobs and the reduced member does the second one. Ubiquinol, the fully reduced form, is a chain-breaking antioxidant in membranes and lipoproteins, regenerating alpha-tocopherol from the tocopheroxyl radical. Roughly 90 to 95 percent of circulating coenzyme Q10 is in the ubiquinol form regardless of which form was swallowed, because plasma enzymes reduce it.

Circulating coenzyme Q10 is carried on lipoproteins, which corrupts the measurement. It travels mainly on LDL. A statin that lowers LDL particle number therefore lowers total plasma coenzyme Q10 arithmetically, without anything happening to tissue content. Reported plasma concentrations should be normalized to cholesterol, and frequently are not Mantle 2023.

And uptake into the tissue is not a diffusion problem. Coenzyme Q10 taken up from lipoproteins has to be delivered into mitochondria, and ex vivo work using coenzyme Q10-enriched LDL from supplemented subjects shows that skeletal muscle cell uptake depends on the formulation the LDL was loaded from Marcheggiani 2023. Plasma is a compartment, not a destination.

Cell, rodent, human — and where it stops

This is the cleanest measured example in the cohort of a plasma number rising while the tissue it was standing in for does not.

In humans the plasma marker is trivially easy to move. Any oral coenzyme Q10 at 100 to 300 mg raises plasma concentration severalfold within weeks. Every supplement trial in this literature confirms that, which is why almost all of them report it.

Somebody then measured the muscle. A double-blinded randomized placebo-controlled trial in statin-treated patients supplemented coenzyme Q10 and measured skeletal muscle coenzyme Q10 content alongside plasma and symptoms; plasma rose and muscle content and muscle symptoms did not follow Dohlmann 2022. That single design decision — biopsy the tissue rather than trust the plasma — is what separates this from the rest of the field.

The meta-analytic picture on statin myopathy is consistent with that. Pooled randomized trials of coenzyme Q10 for statin-induced myopathy report inconsistent and generally small effects on muscle symptoms Wei 2022, and a more recent double-blind trial in older adults with statin-associated asthenia used physical performance as the endpoint rather than a symptom scale Fogacci 2024.

The one indication with a hard outcome is a different disease and a different dose. Q-SYMBIO randomized patients with chronic heart failure to 300 mg a day of coenzyme Q10 or placebo and reported reduced major adverse cardiovascular events and mortality over two years Mortensen 2014. That is a genuine endpoint trial in people with a failing myocardium and a plausible bioenergetic deficit.

The obstacle to transfer is the population, and it is a large one. Extending a heart failure result at 300 mg to a healthy adult taking 100 mg for energy assumes the mechanism is the same in a heart that is not failing. Nothing establishes that, and the muscle biopsy result argues against it Dohlmann 2022.

CoQ10 — which form, and does it matter

Ubiquinol against ubiquinone is the loudest form claim in this catalog and the evidence is softer than the price difference suggests. A review comparing the oxidized and reduced forms as cardiovascular supplements finds no consistent demonstration that ubiquinol is clinically superior, notwithstanding its better solubility Fladerer 2023. Both raise plasma coenzyme Q10; the gut and plasma interconvert them regardless.

The real absorption variable is the lipid vehicle, not the oxidation state. Coenzyme Q10 is a large, crystalline, extremely lipophilic molecule with negligible water solubility; absorption is by micellar solubilization and lymphatic transport with dietary fat, bypassing hepatic first-pass metabolism the way other fat-soluble nutrients do. A powder-filled capsule taken with water can deliver a small fraction of what the same dose in an oil suspension delivers with a meal.

Formulation now has a mechanistic read-out rather than only a plasma one. Phytosome complexation improved cellular ubiquinone uptake into skeletal muscle cells in an ex vivo model that used coenzyme Q10-enriched LDL obtained from people who had taken the supplement Marcheggiani 2023. That design tests delivery to the cell rather than arrival in the blood, which is the step the biopsy trial found missing.

The clock is slow at both ends. Peak plasma concentration arrives roughly 6 hours after a dose, with a secondary peak at around 24 hours from enterohepatic recirculation, and an elimination half-life of about 33 hours. Steady state takes 2 to 4 weeks, and washout takes a similar period. Elimination is predominantly biliary rather than by renal clearance, and there is no significant cytochrome metabolism — which is why the interaction list is short and mostly pharmacodynamic Mantle 2023.

Absorption is saturable, so splitting beats stacking. Single doses above roughly 200 mg show diminishing returns. Two 100 mg doses with fat-containing meals deliver more than one 200 mg dose, and far more than 200 mg taken on an empty stomach, which is how a great many people take it.

What would have to be true, and how you would know it was not

1. Plasma coenzyme Q10 rises severalfold and proves nothing. Predict coenzyme Q10 measured in plasma rises within 2 to 4 weeks on 100 to 200 mg taken with fat, in essentially everybody. Predict it rises less on an empty stomach and less again from a dry powder capsule.

2. Predict the muscle does not follow, and treat that as the central claim of this page. Predict no change in muscle coenzyme Q10 content and no change in statin-associated muscle symptoms at 8 to 12 weeks Dohlmann 2022 Wei 2022. A randomized trial with paired muscle biopsies showing tissue loading and symptom improvement would falsify this page.

3. Predict the statin question is settled by stopping, not by supplementing. If muscle symptoms on a statin are the reason for buying this, predict that a supervised statin washout and rechallenge answers the question in weeks, and that a supplement does not. Track creatine kinase and the symptom itself, and note that most statin-associated muscle symptoms do not come with a raised creatine kinase.

4. Predict a real effect in the population that has one. In chronic heart failure at 300 mg a day, predict measurable changes in functional class and in exercise capacity over months, on the basis of the one endpoint trial in this literature Mortensen 2014. That prediction belongs to a diagnosed population under care, and is a reason to raise it with a cardiologist rather than to self-manage.

5. Predict physical performance, not fatigue rating, is where the honest test lives. In older adults, predict a measurable change in a timed physical performance battery or in grip strength if anything real is happening, and predict a self-reported energy scale moves whether or not it is Fogacci 2024.

What nobody has tested yet

Nobody knows whether statins lower coenzyme Q10 inside mitochondria. The plasma fall is confounded by the LDL fall, and muscle content data are sparse and inconsistent Mantle 2023. Until somebody measures mitochondrial coenzyme Q10 in statin users properly, the entire rationale for this product rests on a compartment that may not be the relevant one.

The Q-SYMBIO result has never been replicated. A single randomized trial reporting a mortality benefit for a supplement in heart failure is an extraordinary result that has stood for over a decade without an adequately powered replication Mortensen 2014. That absence is the most conspicuous gap in this literature.

The formulation question has never been taken to a clinical endpoint. Delivery to muscle cells improves with formulation in an ex vivo system Marcheggiani 2023, and no trial has randomized a high-delivery formulation against a conventional one with a symptom or performance endpoint. That is the study the biopsy trial's null result makes necessary.

And the dose ceiling is unexplored upward. Doses of 1,200 to 2,400 mg a day have been used in neurological trials, and the supplement market stops at 300. Whether the difference between a null and a signal in muscle is a dose difference has not been tested at supplement doses Wei 2022.

CoQ10 — its own safety story, not its category's

Direct toxicity is very low and the trials support that. Doses up to 1,200 mg a day have been used for months without a consistent adverse signal; nausea, appetite loss, epigastric discomfort and loose stools are the usual reports and are reduced by splitting the dose Mantle 2023.

The interaction that matters is with warfarin and it is structural. Coenzyme Q10 is a benzoquinone with a long isoprenoid tail, structurally similar to vitamin K2 menaquinones, and reduced anticoagulant effect has been reported. Anyone on warfarin should expect to recheck the international normalized ratio after starting or stopping it rather than assume nothing will happen.

Blood pressure and glucose can drift down. Modest reductions in blood pressure have been reported in meta-analyses, and small reductions in fasting glucose. Both are additive with medication rather than independent of it, which matters most in somebody already at target.

Timing is a safety detail in one direction only. Because the half-life is about 33 hours and the peak is late, an evening dose is fine for most people; a small number report sleep disturbance and do better taking it in the morning. There is no pharmacological reason to expect either.

Who should raise it with a clinician first. Anyone on warfarin. Anyone taking it for statin muscle symptoms, because the decision that actually matters is about the statin. And anyone with heart failure, because the one indication with an endpoint trial is also the one where the dose is triple the label and the condition needs managing Mortensen 2014. Nothing here is medical advice or diagnosis, and these statements have not been evaluated by the Food and Drug Administration.

Sources read for this page

• Mortensen SA, et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO, a randomized double-blind trial. JACC: Heart Failure 2014 · PMID 25282031
• Wei H, et al. Effects of coenzyme Q10 supplementation on statin-induced myopathy: a meta-analysis of randomized controlled trials. Irish Journal of Medical Science 2022 · PMID 33999383
• Dohlmann TL. Coenzyme Q10 Supplementation in Statin Treated Patients: A Double-Blinded Randomized Placebo-Controlled Trial. Antioxidants (Basel) 2022 · PMID 36139772
• Fladerer JP, et al. Comparison of Coenzyme Q10 (Ubiquinone) and Reduced Coenzyme Q10 (Ubiquinol) as Supplement to Prevent Cardiovascular Disease and Reduce Cardiovascular Mortality. Current Cardiology Reports 2023 · PMID 37971634
• Mantle D, et al. Coenzyme Q10 Metabolism: A Review of Unresolved Issues. International Journal of Molecular Sciences 2023 · PMID 36768907
• Fogacci F, et al. Effect of Coenzyme Q10 on Physical Performance in Older Adults with Statin-Associated Asthenia: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial. Journal of Clinical Medicine 2024 · PMID 38999304
• Marcheggiani F, et al. CoQ10Phytosomes Improve Cellular Ubiquinone Uptake in Skeletal Muscle Cells: An Ex Vivo Study Using CoQ10-Enriched Low-Density Lipoproteins Obtained in a Randomized Crossover Study. Antioxidants (Basel) 2023 · PMID 37107339

How you would know if it worked

CoQ10 — safety & side effects

Bloodwork to run alongside CoQ10

Baseline first, then again at 8–12 weeks.

The Real Cardiovascular Risk panel covers these in one order — 9 markers, $187.60 with the discount applied.

Check results you already have → · All 103 markers A–Z

CoQ10 — frequently asked questions

CoQ10 inside a finished plan

One arm of 2 Protocol Blueprints, free to read in full.

What CoQ10 is used for

CoQ10 appears under 6 goals in the goal router.

Related Longevity & Antioxidants supplements

← Browse the full Supplement Vault

↑ Back to on this page